Tag: Needham
Patient volume slows for sleep, oxygen, report finds
October 28, 2024HME News Staff
NEW YORK – Respondents to Needham’s latest Sleep and Oxygen Survey report they saw slower sleep patient volume growth in the last 12 months, and they expect that to continue for the next 12 months. They report they have seen virtually no impact on their sleep patient volume from GLP-1 drugs. They also report ResMed will hold flow generator share but lose mask share over the next 12 months. For oxygen, respondents saw slower oxygen patient volume growth in the last 12 months, and they...
Survey finds improving supply for CPAP devices
March 18, 2024HME News Staff
NEW YORK – Respondents saw a 6% increase in sleep patient volume, on average, in the last 12 months, according to the HME Sleep and Oxygen Survey for the first quarter of 2024 from Needham and Co.
Respondents expect 6.5% growth in the next 12 months.
“We suspect that the increase is due to improving flow generator supply and HMEs engaging both new and backlogged patients that resulted from the Philips Respironics recall,” the report stated.
Other...
Survey: Sleep volume growth anticipated
May 3, 2023HME News Staff
NEW YORK – Providers expect to see double-digit growth in their sleep patient volume over the next 12 months as flow-generator availability improves, according to the first quarter 2023 HME Sleep and Oxygen Survey from Needham.
Respondents reported that they have been able to purchase their desired flow generators within required timeframes as follows: Philips, 15.6% (up from 12.1% in Q3 2022); Fisher & Paykel, 25% (up from 9.4% in Q3 2022); and ResMed, 61.4% (up from 39.2% in Q3 2022).
The...
Report: Providers anticipate sleep rebound
September 28, 2022HME News Staff
NEW YORK – HME providers saw a 6.3% decline in their sleep patient volume in the last 12 months, but they expect double-digit growth in the next 12 months, according to the third quarter HME Sleep and Oxygen Survey from Needham.
The decline in sleep is mainly due to a shortage in flow generators. The eventual re-entry of Philips into the flow generator market appears likely to come mostly at the expense of smaller competitors rather than ResMed, according to the survey.
Respondents...
Report: Recall causes shifts in sleep therapy market
April 5, 2022HME News Staff
NEW YORK – HME providers expect to shift an average of 58.4% of their Philips Respironics flow generator purchases and an average of 30.2% of their mask purchases to other companies due to the recall, according to the first quarter HME Sleep and Oxygen Survey from Needham.
That’s up from the 56% and 23.1%, respectively, reported in the third quarter survey.
“ResMed should gain market share over the (next 12 months),” the survey states. “Respondents...
Recall will shift buying preferences, survey finds
August 10, 2021HME News Staff
NEW YORK – Providers expect to permanently shift an average of 56% of their Philips flow generator purchases and an average of 23.1% of their Philips mask purchases to other companies due to the recall, according to Needham’s 3Q21 HME Sleep and Oxygen Survey.
“And ResMed looks likely to be a beneficiary of this share movement,” Needham states. “Over the near-term, respondents expect ResMed’s share of their flow generator purchases to increase by 3.7% and...
Pandemic impacts patient volume, survey says
June 3, 2020HME News Staff
NEW YORK - Respondents report, on average, a 4.1% decline in their sleep resupply business due to the COVID-19 pandemic in the “2Q20 HME Oxygen, Sleep and Complex Rehab Survey by Needham and HME News.”Respondents saw their sleep patient volume increase by 5.5% in the last 12 months before the pandemic and expect their volume to grow by 5% over the next 12 months.“Both of these growth rates are lower than our prior survey results of 15% and 15.3%, respectively,” writes analyst...
Survey predicts nice bump in POC adoption
January 29, 2020HME News Staff
NEW YORK - Portable oxygen concentrators are expected to increase from 23.9% of the ambulatory oxygen market to 28.2% over the next 12 months, according to the results of a new survey from Needham.Respondents expect 11.3% growth in their POC unit purchases over the next 12 months, with Applied Home Healthcare's OxyGo and Inogen's G4 the two highest rated devices, according to the 4Q19 HME Oxygen, Sleep and Complex Rehab Survey of 48 companies.“Inogen looks likely to gain market share,”...
Survey: Providers aren't jumping to buy POCs
June 28, 2019HME News Staff
NEW YORK - Providers expect only 2.6% growth in their POC purchases over the next 12 months, according to a new survey from Needham & Company.
This, despite also expecting POCs to increase from 21.5% of the ambulatory oxygen market to 31.5% over the next 12 months, according to the 2Q19 HME Oxygen, Sleep and Complex Rehab Survey.
Additionally, providers report Applied Home Healthcare's OxyGo as the highest rated POC at 5.1 out of 7, followed by Applied's OxyGo Fit.
On the sleep side,...
Providers hold off on ordering—for now
December 20, 2018HME News Staff
NEW YORK - The majority of HME providers are reducing or delaying orders for oxygen and CPAP equipment, but that is likely to be temporary, according to a new survey for the fourth quarter of 2018 from Needham & Company.
Sixty three percent of respondents said they would reduce or delay orders for oxygen equipment in response to an any willing provider provision set to go into effect Jan. 1 for Medicare, according to the survey of 150 providers.
Respondents said they would also reduce or delay...